Details for New Drug Application (NDA): 050404
✉ Email this page to a colleague
NDA 050404 describes AUREOMYCIN, which is a drug marketed by Lederle and is included in one NDA. Additional details are available on the AUREOMYCIN profile page.
The generic ingredient in AUREOMYCIN is chlortetracycline hydrochloride. There are twelve drug master file entries for this compound. Additional details are available on the chlortetracycline hydrochloride profile page.
The generic ingredient in AUREOMYCIN is chlortetracycline hydrochloride. There are twelve drug master file entries for this compound. Additional details are available on the chlortetracycline hydrochloride profile page.
Summary for 050404
| Tradename: | AUREOMYCIN |
| Applicant: | Lederle |
| Ingredient: | chlortetracycline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050404
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
